Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

IMV Inc IMVIF

Healthcare Biotechnology
IMV Inc. is a Canada-based company. The Company has no business operations.


GREY:IMVIF - Post by User

IMV Inc
Bullboard Posts
User Avatar Image
(17)
•••
Comment by alphaseeking001on May 18, 2018 1:04pm
141 Views
Post# 28053272

RE:RE:Comments on IMV

RE:RE:Comments on IMVIt is a very interesting comparison for sure... one other thing however is that back when LOXO was in a similar stage to IMV (LOXO at $25/share).... their market cap was $750 million USD, while ours right now is only $270 million USD.  Hence, if we are at a roughly comparable stage... our market cap would have to almost go up 3x just to get to where LOXO was at a similar stage in 2016!  Hence, NASDAQ exposure and some good results could be very interesting indeed...
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities